Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Neutropenia × posaconazole × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 3 Myelodysplastic Syndromes 2 Neutropenia 1 Mycoses 1 Anemia, Aplastic 1

Interventions

pegfilgrastim 3 Filgrastim 2 posaconazole 1 pegylated granulocyte colony-stimulating factor 1 Vascular Access Devices 1 Vancomycin 1 Teicoplanin 1 Leucovorin 1 Lenograstim 1 Irinotecan 1 Fluorouracil 1 Ciprofloxacin 1 Ceftazidime 1 Cefepime 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00686543 2017-04-07

Oral Posaconazole in High Risk Patients With Gastrointestinal Dysfunction (Study P05115)

Merck Sharp & Dohme LLC

Phase 4 Completed

75 enrolled 14 charts

Other hematologic neoplasm

Mycoses, Neutropenia, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡